Insights

Strategic Expansion Batavia Biosciences recently launched new biomanufacturing facilities and services, including Batavia Biomanufacturing and the GMP-ready Amalia facility, providing opportunities to engage with clients seeking comprehensive bioprocessing support from clinical to commercial stages.

Innovative Technologies The company’s development of advanced upstream bioprocessing platforms like HIP-Vax positions it as a cutting-edge partner for vaccine manufacturers looking to optimize production processes, especially for complex vaccines such as polio.

Strong Industry Partnerships Collaborations with companies like Candel Therapeutics highlight Batavia’s expertise in HSV bioprocessing and modular manufacturing solutions, making it a valuable partner for organizations focusing on gene therapies and specialized biologics.

Focused Market Purpose With a clear commitment to addressing infectious diseases and cancer, Batavia Biosciences offers targeted development and manufacturing services that appeal to biotech firms developing therapies in these high-need areas.

Funding and Growth Supported by substantial funding of 17 million dollars and an employee base of up to 500, Batavia is positioned for growth, making it an attractive partner for clients seeking reliable, innovative CDMO services in the competitive biotech landscape.

Batavia Biosciences Tech Stack

Batavia Biosciences uses 8 technology products and services including Open Graph, JSON-LD, Mailcheck, and more. Explore Batavia Biosciences's tech stack below.

  • Open Graph
    Content Management System
  • JSON-LD
    Javascript Frameworks
  • Mailcheck
    Javascript Libraries
  • Priority Hints
    Performance
  • reCAPTCHA
    Security
  • Google Tag Manager
    Tag Management
  • Bootstrap
    UI Frameworks
  • X-Content-Type-Options
    Web & Portal Technology

Media & News

Batavia Biosciences's Email Address Formats

Batavia Biosciences uses at least 1 format(s):
Batavia Biosciences Email FormatsExamplePercentage
F.Last@bataviabiosciences.comJ.Doe@bataviabiosciences.com
90%
First.Last@bataviabiosciences.comJohn.Doe@bataviabiosciences.com
7%
FirstLast@bataviabiosciences.comJohnDoe@bataviabiosciences.com
2%
FLast@bataviabiosciences.comJDoe@bataviabiosciences.com
1%

Frequently Asked Questions

Where is Batavia Biosciences's headquarters located?

Minus sign iconPlus sign icon
Batavia Biosciences's main headquarters is located at Zernikedreef 16, Leiden, 2333 CL, NL. The company has employees across 4 continents, including EuropeNorth AmericaAsia.

What is Batavia Biosciences's phone number?

Minus sign iconPlus sign icon
You can contact Batavia Biosciences's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Batavia Biosciences's official website and social media links?

Minus sign iconPlus sign icon
Batavia Biosciences's official website is bataviabiosciences.com and has social profiles on LinkedIn.

What is Batavia Biosciences's SIC code NAICS code?

Minus sign iconPlus sign icon
Batavia Biosciences's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Batavia Biosciences have currently?

Minus sign iconPlus sign icon
As of October 2025, Batavia Biosciences has approximately 201 employees across 4 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer: Y. S.Chief Scientific Officer: D. F.Chief Operating Officer: C. Y.. Explore Batavia Biosciences's employee directory with LeadIQ.

What industry does Batavia Biosciences belong to?

Minus sign iconPlus sign icon
Batavia Biosciences operates in the Biotechnology Research industry.

What technology does Batavia Biosciences use?

Minus sign iconPlus sign icon
Batavia Biosciences's tech stack includes Open GraphJSON-LDMailcheckPriority HintsreCAPTCHAGoogle Tag ManagerBootstrapX-Content-Type-Options.

What is Batavia Biosciences's email format?

Minus sign iconPlus sign icon
Batavia Biosciences's email format typically follows the pattern of F.Last@bataviabiosciences.com. Find more Batavia Biosciences email formats with LeadIQ.

How much funding has Batavia Biosciences raised to date?

Minus sign iconPlus sign icon
As of October 2025, Batavia Biosciences has raised $17M in funding. The last funding round occurred on Feb 25, 2019 for $13M.

When was Batavia Biosciences founded?

Minus sign iconPlus sign icon
Batavia Biosciences was founded in 2010.

Batavia Biosciences

Biotechnology ResearchNetherlands201-500 Employees

Batavia Biosciences is a science-based CDMO that offers personalized services that fully support all the stages of biopharmaceutical development, from cloning to GMP manufacture and release of clinical material for phase I/II studies. We are not your standard CDMO - our customers regularly refer to us as their product development partner and thought partner.

We focus on the early stages of product development with services ranging from DNA cloning, mammalian cell line generation, upstream process development, purification development, product characterization to clinical manufacturing. Headquartered in Leiden, The Netherlands, Batavia Biosciences is privileged to have strong strategic partners in both the EU and US.
  
Batavia Biosciences aims to significantly contribute to ease human suffering from infectious disease and cancer.

Section iconCompany Overview

Headquarters
Zernikedreef 16, Leiden, 2333 CL, NL
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2010
Employees
201-500

Section iconFunding & Financials

  • $17M

    Batavia Biosciences has raised a total of $17M of funding over 2 rounds. Their latest funding round was raised on Feb 25, 2019 in the amount of $13Mas a grant.

  • $1M$10M

    Batavia Biosciences's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $17M

    Batavia Biosciences has raised a total of $17M of funding over 2 rounds. Their latest funding round was raised on Feb 25, 2019 in the amount of $13Mas a grant.

  • $1M$10M

    Batavia Biosciences's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.